<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Avalyn Pharma Inc. (AVLN) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/avln/filings</link>
    <description>Latest company filings for Avalyn Pharma Inc. (AVLN) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 00:55:29 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/avln/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[AVLN: SCHEDULE 13D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000107261326000386/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001072613-26-000386</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a SCHEDULE 13D (SCHEDULE 13D) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D</category>
    </item>
    <item>
      <title><![CDATA[AVLN: SCHEDULE 13D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000089914026000428/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000899140-26-000428</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a SCHEDULE 13D (SCHEDULE 13D) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D</category>
    </item>
    <item>
      <title><![CDATA[AVLN: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526212017/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-212017</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000138832526000021/xslF345X06/form4-05052026_040501.xml</link>
      <guid isPermaLink="false">0001388325-26-000021</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526205201/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-205201</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000031506626000743/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000315066-26-000743</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526202381/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-202381</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-04.]]></description>
      <pubDate>Mon, 04 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201894/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201894</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201887/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201887</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201875/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201875</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201870/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201870</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201868/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201868</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201867/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201867</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201865/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201865</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201863/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201863</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201861/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201861</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201860/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201860</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201856/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-201856</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Insider trade (4) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526201434/ck0001540171-20260501.htm</link>
      <guid isPermaLink="false">0001193125-26-201434</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Major company event (8-K) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526197739/ck0001540171-20260430.htm</link>
      <guid isPermaLink="false">0001193125-26-197739</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Employee stock plan (S-8) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[AVLN: 424B4]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526197686/424b4.htm</link>
      <guid isPermaLink="false">0001193125-26-197686</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a 424B4 (424B4) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B4</category>
    </item>
    <item>
      <title><![CDATA[AVLN: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/999999999526001383/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-001383</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a EFFECT (EFFECT) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000138832526000017/xslF345X06/form3-04302026_120434.xml</link>
      <guid isPermaLink="false">0001388325-26-000017</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: Exchange certification (CERT)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000135445726000385/AVLN_8A_Cert_1540171.pdf</link>
      <guid isPermaLink="false">0001354457-26-000385</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a Exchange certification (CERT) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>CERT</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526193328/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-193328</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526193145/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-193145</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192926/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192926</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192838/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192838</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192819/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192819</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192803/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192803</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192773/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192773</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192759/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192759</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192729/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192729</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192688/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192688</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192686/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192686</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192678/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192678</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192661/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192661</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526192655/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-192655</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a New insider ownership (3) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AVLN: S-1/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526189477/ck0001540171-20260429.htm</link>
      <guid isPermaLink="false">0001193125-26-189477</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a S-1/A (S-1/A) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>S-1/A</category>
    </item>
    <item>
      <title><![CDATA[AVLN: 8-A12B]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526182253/avalyn_pharma_-_form_8-a.htm</link>
      <guid isPermaLink="false">0001193125-26-182253</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a 8-A12B (8-A12B) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-A12B</category>
    </item>
    <item>
      <title><![CDATA[AVLN: S-1/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526173632/ck0001540171-20260423.htm</link>
      <guid isPermaLink="false">0001193125-26-173632</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a S-1/A (S-1/A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>S-1/A</category>
    </item>
    <item>
      <title><![CDATA[AVLN: IPO registration (S-1)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526147573/ck0001540171-20260408.htm</link>
      <guid isPermaLink="false">0001193125-26-147573</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a IPO registration (S-1) on 2026-04-08.]]></description>
      <pubDate>Wed, 08 Apr 2026 12:00:00 GMT</pubDate>
      <category>S-1</category>
    </item>
    <item>
      <title><![CDATA[AVLN: DRS/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526113967/filename1.htm</link>
      <guid isPermaLink="false">0001193125-26-113967</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a DRS/A (DRS/A) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>DRS/A</category>
    </item>
    <item>
      <title><![CDATA[AVLN: DRS]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000119312526040979/filename1.htm</link>
      <guid isPermaLink="false">0001193125-26-040979</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a DRS (DRS) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>DRS</category>
    </item>
    <item>
      <title><![CDATA[AVLN: D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000154017123000001/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001540171-23-000001</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a D (D) on 2023-10-10.]]></description>
      <pubDate>Tue, 10 Oct 2023 12:00:00 GMT</pubDate>
      <category>D</category>
    </item>
    <item>
      <title><![CDATA[AVLN: D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000154017120000002/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001540171-20-000002</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a D (D) on 2020-05-08.]]></description>
      <pubDate>Fri, 08 May 2020 12:00:00 GMT</pubDate>
      <category>D</category>
    </item>
    <item>
      <title><![CDATA[AVLN: D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000114036117022149/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001140361-17-022149</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a D/A (D/A) on 2017-05-24.]]></description>
      <pubDate>Wed, 24 May 2017 12:00:00 GMT</pubDate>
      <category>D/A</category>
    </item>
    <item>
      <title><![CDATA[AVLN: D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000114036117013115/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001140361-17-013115</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a D (D) on 2017-03-24.]]></description>
      <pubDate>Fri, 24 Mar 2017 12:00:00 GMT</pubDate>
      <category>D</category>
    </item>
    <item>
      <title><![CDATA[AVLN: D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000114036115031315/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001140361-15-031315</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a D/A (D/A) on 2015-08-12.]]></description>
      <pubDate>Wed, 12 Aug 2015 12:00:00 GMT</pubDate>
      <category>D/A</category>
    </item>
    <item>
      <title><![CDATA[AVLN: D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1540171/000114036115013063/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001140361-15-013063</guid>
      <description><![CDATA[Avalyn Pharma Inc. filed a D/A (D/A) on 2015-03-24.]]></description>
      <pubDate>Tue, 24 Mar 2015 12:00:00 GMT</pubDate>
      <category>D/A</category>
    </item>
  </channel>
</rss>